blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1723143

EP1723143 - AMINO CYCLOPROPANE CARBOXAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.12.2009
Database last updated on 20.09.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY, TR		published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
[2006/47]
Inventor(s)01 / BOCK, Mark, G.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
02 / FENG, Dong-Mei
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
03 / KUDUK, Scott
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
 [2006/47]
Representative(s)Buchan, Gavin MacNicol, et al
Merck Sharp & Dohme Limited
European Patent Department
Hertford Road
Hoddesdon
Hertfordshire EN11 9BU / GB
[N/P]
Former [2006/48]Buchan, Gavin MacNicol, et al
Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon
Hertfordshire, EN11 9BU / GB
Former [2006/47]Buchan, Gavin MacNicol, et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date05714101.225.02.2005
[2006/47]
WO2005US06230
Priority number, dateUS20040549379P02.03.2004         Original published format: US 549379 P
[2006/47]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005085198
Date:15.09.2005
Language:EN
[2005/37]
Type: A2 Application without search report 
No.:EP1723143
Date:22.11.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 15.09.2005 takes the place of the publication of the European patent application.
[2006/47]
Type: B1 Patent specification 
No.:EP1723143
Date:18.02.2009
Language:EN
[2009/08]
Search report(s)International search report - published on:EP24.11.2005
ClassificationIPC:C07D413/12
[2006/47]
CPC:
C07D401/12 (EP,US); A61P1/02 (EP); A61P1/16 (EP);
A61P1/18 (EP); A61P11/00 (EP); A61P11/02 (EP);
A61P11/06 (EP); A61P13/08 (EP); A61P13/10 (EP);
A61P13/12 (EP); A61P15/00 (EP); A61P17/00 (EP);
A61P17/02 (EP); A61P17/06 (EP); A61P19/00 (EP);
A61P19/02 (EP); A61P19/06 (EP); A61P19/10 (EP);
A61P21/00 (EP); A61P21/02 (EP); A61P25/00 (EP);
A61P25/02 (EP); A61P25/06 (EP); A61P25/08 (EP);
A61P25/16 (EP); A61P25/28 (EP); A61P27/02 (EP);
A61P27/16 (EP); A61P29/00 (EP); A61P3/10 (EP);
A61P31/04 (EP); A61P31/12 (EP); A61P35/00 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P5/24 (EP);
A61P7/00 (EP); A61P7/10 (EP); A61P9/00 (EP);
A61P9/02 (EP); A61P9/04 (EP); A61P9/10 (EP);
C07D213/61 (EP,US); C07D405/12 (EP,US); C07D409/12 (EP,US);
C07D413/12 (EP,US); C07D417/12 (EP,US); Y10T407/28 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/47]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
LV02.10.2006
MKNot yet paid
YUNot yet paid
TitleGerman:AMINOCYCLOPROPANCARBONSÄUREAMIDDERIVATE ALS BRADYKININANTAGONISTEN[2006/47]
English:AMINO CYCLOPROPANE CARBOXAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS[2006/47]
French:DERIVES D AMINO CYCLOPROPANE CARBOXAMIDE UTILISES COMME ANTAGONISTES DE LA BRADYKININE[2006/47]
Entry into regional phase02.10.2006National basic fee paid 
02.10.2006Designation fee(s) paid 
02.10.2006Examination fee paid 
Examination procedure02.10.2006Examination requested  [2006/47]
12.07.2007Despatch of a communication from the examining division (Time limit: M06)
22.01.2008Reply to a communication from the examining division
04.04.2008Despatch of a communication from the examining division (Time limit: M01)
08.05.2008Reply to a communication from the examining division
29.08.2008Communication of intention to grant the patent
22.12.2008Fee for grant paid
22.12.2008Fee for publishing/printing paid
Opposition(s)19.11.2009No opposition filed within time limit [2010/04]
Fees paidRenewal fee
05.02.2007Renewal fee patent year 03
08.02.2008Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT18.02.2009
BE18.02.2009
CY18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
IT18.02.2009
LT18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
TR18.02.2009
IE25.02.2009
LU25.02.2009
MC28.02.2009
BG18.05.2009
SE18.05.2009
GR19.05.2009
ES29.05.2009
IS18.06.2009
PT27.07.2009
HU19.08.2009
[2011/44]
Former [2011/32]AT18.02.2009
BE18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
IT18.02.2009
LT18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
IE25.02.2009
LU25.02.2009
MC28.02.2009
BG18.05.2009
SE18.05.2009
GR19.05.2009
ES29.05.2009
IS18.06.2009
PT27.07.2009
HU19.08.2009
Former [2011/22]AT18.02.2009
BE18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
IT18.02.2009
LT18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
IE25.02.2009
LU25.02.2009
MC28.02.2009
BG18.05.2009
SE18.05.2009
GR19.05.2009
ES29.05.2009
IS18.06.2009
PT27.07.2009
Former [2011/15]AT18.02.2009
BE18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
IT18.02.2009
LT18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
IE25.02.2009
MC28.02.2009
BG18.05.2009
SE18.05.2009
GR19.05.2009
ES29.05.2009
IS18.06.2009
PT27.07.2009
Former [2010/52]AT18.02.2009
BE18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
LT18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
IE25.02.2009
MC28.02.2009
BG18.05.2009
SE18.05.2009
GR19.05.2009
ES29.05.2009
IS18.06.2009
PT27.07.2009
Former [2010/12]AT18.02.2009
BE18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
LT18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
IE25.02.2009
MC28.02.2009
BG18.05.2009
SE18.05.2009
ES29.05.2009
IS18.06.2009
PT27.07.2009
Former [2010/07]AT18.02.2009
BE18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
LT18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
IE25.02.2009
MC28.02.2009
SE18.05.2009
ES29.05.2009
IS18.06.2009
PT27.07.2009
Former [2009/52]AT18.02.2009
BE18.02.2009
CZ18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
LT18.02.2009
NL18.02.2009
PL18.02.2009
RO18.02.2009
SI18.02.2009
SK18.02.2009
MC28.02.2009
SE18.05.2009
ES29.05.2009
IS18.06.2009
PT27.07.2009
Former [2009/48]AT18.02.2009
BE18.02.2009
DK18.02.2009
EE18.02.2009
FI18.02.2009
LT18.02.2009
NL18.02.2009
PL18.02.2009
SI18.02.2009
MC28.02.2009
SE18.05.2009
ES29.05.2009
IS18.06.2009
Cited inInternational search[Y]WO03065789  (MERCK & CO INC [US], et al) [Y] 1-10 * claims 1-41 *;
 [Y]WO03066577  (MERCK & CO INC [US], et al) [Y] 1-10* claims 1-42 *;
 [PX]WO2004019868  (MERCK & CO INC [US], et al) [PX] 1-10 * claims 1-20,24-32 *;
 [PX]WO2005016886  (MERCK & CO INC [US], et al) [PX] 1-10 * claims 1-3,5,6,11-13 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.